Loading
Latest filing published 10 Jun 2026 for 아리바이오LAB.
No signal scores available.
Not enough history yet: 1 closed purchase, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
소룩스, listed as chief executive, has filed trades across 2 companies (mainly through DART (FSS)), most often in 차백신연구소 and 아리바이오LAB. Over a trading history stretching from 18 March 2026 to 10 June 2026, the count stands at 3 filings.
On the market, this insider has only ever bought: 1 purchase, €12.0M in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The record was last updated on 10 June 2026 with a transaction in 아리바이오LAB. The last purchase on record was published on 25 March 2026, which is 214 days ago. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.